Zobrazeno 1 - 10
of 21
pro vyhledávání: '"Thomas Systchenko"'
Autor:
Paul Loubet, Benjamin Gaborit, Mathilde Salpin, Hèlene Gardeney, Ilies Benotmane, Thomas Systchenko
Publikováno v:
Human Vaccines & Immunotherapeutics, Vol 20, Iss 1 (2024)
France was the first country to grant Sipavibart (AZD3152, an investigational long-acting monoclonal antibody) as a COVID-19 pre-exposure prophylaxis treatment in immunocompromised individuals in December 2023. The first patients to receive Sipavibar
Externí odkaz:
https://doaj.org/article/1e33f7c4698e4801b92f13b3d35ed9e6
Autor:
Laura Cailly, Cécile Gruchet, Elsa Maitre, Stephanie Guidez, Vincent Delwail, Thomas Systchenko, Niels Moya, Florence Sabirou, Anthony Levy, Arthur Bobin, Hélène Gardeney, Laly Nsiala, Mathilde Vonfeld, Aurélia Chacon, Aurélien Pichon, Sabrina Bouyer, Caroline Baslé, Elodie Dindinnaud, Jean‐Claude Chomel, Anna Raimbault, Florence Borde‐Mougenot, Xavier Troussard, Cécile Tomowiak
Publikováno v:
Clinical Case Reports, Vol 11, Iss 5, Pp n/a-n/a (2023)
Key Clinical Message 18F‐FDG PET/CT has clinical relevance in HCL at diagnosis and for the follow‐up of patients treated, especially in case of atypical presentations such as bone involvements (which are probably underestimated) and poor bone mar
Externí odkaz:
https://doaj.org/article/a1f77fb06fad4b2893f4fd5cc094f5c0
Autor:
Loïc Renaud, Susanna Schraen, Guillemette Fouquet, Stephanie Guidez, Hélène Demarquette, Morgane Nudel, Emilie Cayssials, Claire Bories, Charles Herbaux, Thomas Systchenko, Jean‐Luc Faucompré, Antoine Machet, Florence Sabirou, Antony Levy, Arthur Bobin, Valentine Richez, Niels Moya, Cécile Gruchet, Deborah Desmier, Zoe van deWyngaert, Benjamin Carpentier, Salomon Manier, Thierry Facon, Stephen Harding, Xavier Leleu
Publikováno v:
Cancer Medicine, Vol 8, Iss 8, Pp 3822-3830 (2019)
Abstract Background Streptococcus pneumoniae infection causes morbidity and mortality in multiple myeloma patients. Pneumococcal vaccination is commonly given to immunocompromised myeloma patients; however response data are sparse. Here, we present l
Externí odkaz:
https://doaj.org/article/80b5e0da095642008a7edbdd58b324e1
Autor:
Thomas Systchenko, Jean‐Claude Chomel, Pilar Gallego‐Hernanz, Niels Moya, Déborah Desmier, Natacha Maillard, Arthur Bobin, Mathilde Vonfeld, Hélène Gardeney, Emilie Cayssials E, José Torregrosa
Publikováno v:
British Journal of Haematology.
Autor:
Antoine Machet, Caroline Poudou, Cécile Tomowiak, Thomas Gastinne, Martine Micheline Gardembas, Thomas Systchenko, Niels Moya, Céline Debiais, Anthony Levy, Cécile Gruchet, Florence Sabirou, Stéphanie Noel, Sabrina Bouyer, Xavier Leleu, Vincent Delwail, Stéphanie Guidez
Publikováno v:
Blood Advances.
Preservation of fertility has become a growing concern in young females with Hodgkin lymphoma (HL). However, the rate of pregnancy after the current most frequently prescribed ABVD chemotherapy for HL has rarely been studied. We aimed to determine th
Autor:
Xavier Leleu, Jean-Claude Chomel, André Herbelin, Carine Motard, Stéphanie Ragot, Florence Tartarin, Anne Corby, Guillaume Denis, Jose Torregrosa-Diaz, Deborah Desmier, Thomas Systchenko, Lydia Roy, Jean-Marc Gombert, Emmanuel Fleck, Emilie Cayssials, Pilar Gallego-Hernanz, François Guilhot, Antoine Machet, Natacha Maillard
Publikováno v:
Cancer. 126:3438-3447
Background Long-term treatment-free remission (TFR) represents a new goal for chronic myeloid leukemia (CML). In clinical practice, tyrosine kinase inhibitor (TKI) dose reductions can be considered a means of preventing adverse effects and improving
Autor:
Pierre Ingrand, Vincent Delwail, A Machet, Stéphanie Guidez, C Debiais-Delpech, Mathieu Puyade, C Laurent, Xavier Leleu, Brigitte Dreyfus, Thomas Systchenko, Gautier Defossez
Publikováno v:
Annals of Hematology. 99:1605-1613
Second primary diffuse large B cell lymphoma (spDLBCL) is defined as a metachronous tumor occurring after a first primary cancer. To date, while R-CHOP is the standard first-line treatment for de novo DLBCL, no available data show that R-CHOP is the
Autor:
Lionel Karlin, Arnaud Jaccard, Margaret Macro, Cyrille Touzeau, Jean-Henri Bourhis, Arthur Bobin, Nabih Azar, Xavier Leleu, Denis Caillot, Guillemette Fouquet, Claire Darras, Laurent Garderet, Thomas Systchenko, Erik Deconinck, Samuel Limat, Cécile Gruchet, Philippe Moreau, Pascal Lenain, Isabelle Princet, Zoé Van de Wyngaert, Virginie Nerich, Christine Giraud, Marie-Lorraine Chretien, Cyrille Hulin, Ramdane Belhocine, Niels Moya, Stéphanie Guidez
Publikováno v:
Bone Marrow Transplantation. 55:2254-2260
Mobilization of peripheral blood stem cells (PBSC) can be performed using plerixafor, which is expensive, or high-dose cyclophosphamide (HDCy). We hypothesized that the overall cost of mobilization with plerixafor might not be greater if the cost of
Autor:
Emmanuel Fleck, Vincent Delwail, Isabelle Princet, Arthur Bobin, Xavier Leleu, Thomas Systchenko, Elodie Dindinaud, Anthony Levy, Niels Moya, Laly Nsiala, Stéphanie Guidez, Anne Corby, Celine Dieval, Gaelle Olivier, Florence Sabirou, Laura Cailly, Carine Motard, Sabrina Bouyer, Christophe Roul, Guillaume Denis, Cécile Tomowiak, Cécile Gruchet, Céline Debiais, Helene Gardeney
Publikováno v:
Leukemialymphoma. 62(11)
Primary or secondary immune deficiency (ID) is a risk factor, although rare, to develop Waldenström macroglobulinemia (WM). We aimed to better understand the incidence of this occurrence in the real-life and the outcome of either entity. We conducte
Autor:
Thierry Facon, Antoine Machet, Florence Sabirou, Arthur Bobin, Thomas Systchenko, Emilie Cayssials, Zoé Van de Wyngaert, Guillemette Fouquet, Stephen Harding, Jean-Luc Faucompré, Morgane Nudel, Benjamin Carpentier, Xavier Leleu, Deborah Desmier, Antony Levy, Cécile Gruchet, Susanna Schraen, Hélène Demarquette, Loïc Renaud, Salomon Manier, Valentine Richez, Charles Herbaux, Claire Bories, Niels Moya, Stéphanie Guidez
Publikováno v:
Cancer Medicine
Cancer Medicine, Vol 8, Iss 8, Pp 3822-3830 (2019)
Cancer Medicine, Vol 8, Iss 8, Pp 3822-3830 (2019)
Background Streptococcus pneumoniae infection causes morbidity and mortality in multiple myeloma patients. Pneumococcal vaccination is commonly given to immunocompromised myeloma patients; however response data are sparse. Here, we present longitudin